STRAP

Serine-threonine kinase receptor-associated protein · Q9Y3F4 · STRAP on Sugi Atlas →

0 patent compounds predicted against STRAP, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to STRAP by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity PHASE4COMPLETED
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus PHASE3UNKNOWN
Signal TrAnsduction Pathway Activity Analysis in OVarian cancER PHASE2/PHASE3RECRUITING
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer PHASE2COMPLETED
Trial of Metformin for Colorectal Cancer Risk Reduction for History of Colorectal Adenomas and Elevated BMI PHASE2COMPLETED
I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers PHASE1/PHASE2NOT_YET_RECRUITING
Metformin and Simvastatin Use in Bladder Cancer PHASE2UNKNOWN
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients PHASE1/PHASE2WITHDRAWN
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas PHASE2SUSPENDED
Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma PHASE1/PHASE2COMPLETED
Study in Adult Ph-positive ALL PHASE2UNKNOWN
Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer PHASE2COMPLETED
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis PHASE1/PHASE2COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors PHASE1ACTIVE_NOT_RECRUITING
Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer EARLY_PHASE1COMPLETED
Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery EARLY_PHASE1COMPLETED
Lymphoid Tyrosine Phosphatase Gene Polymorphisms in Inflammatory Bowel Disease nanUNKNOWN
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
p-AKT Expression on Clinical Outcomes in Malignant Lymphoma nanCOMPLETED
The Effect Of DAAs on miRNA-122 And Insulin Resistance In Chronic HCV Patients nanUNKNOWN
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma nanCOMPLETED
Ischemic Preconditioning to Prevent Acute Kidney Injury nanCOMPLETED
Association Between Intakes of Protein, Calcium and Milk With Gene Expression and Linear Growth of School Aged Children nanCOMPLETED
Limb RIPC in Patients Undergoing Lung Lobectomy. Study of Oxidative Lung Damage nanCOMPLETED
MOLECULAR REGULATION OF MUSCLE GLUCOSE METABOLISM (AIMS 2A, 2B, 3) nanUNKNOWN
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure nanUNKNOWN
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a STRAP binder may also engage these)

ProteinNameSimilarity
Q5E959 1.000 Q5E959 →
Q9Z1Z2 1.000 Q9Z1Z2 →
Q5XIG8 0.999 Q5XIG8 →
Q5ZL33 0.995 Q5ZL33 →
B0BNA7 0.985 B0BNA7 →
Q9QZD9 0.985 Q9QZD9 →
B0XYC8 0.983 B0XYC8 →
EIF3I Eukaryotic translation initiation factor 3 subunit I 0.982 landscape →
Q7RXH4 0.982 Q7RXH4 →
Q5IH81 0.981 Q5IH81 →
Q0CXH9 0.981 Q0CXH9 →
Q4WX90 0.981 Q4WX90 →
Q66J51 0.981 Q66J51 →
Q5E966 0.980 Q5E966 →
A1D7I5 0.980 A1D7I5 →
A1CJY4 0.980 A1CJY4 →
Q5EBE8 0.980 Q5EBE8 →
B5FZ19 0.980 B5FZ19 →
Q38884 0.979 Q38884 →
Q2GTM8 0.978 Q2GTM8 →
A6RUL1 0.978 A6RUL1 →
Q5R7R2 0.978 Q5R7R2 →
A7EF03 0.977 A7EF03 →
Q2UQ34 0.977 Q2UQ34 →
Q5B8Y3 0.976 Q5B8Y3 →
A2QEV8 0.975 A2QEV8 →
B6QC56 0.975 B6QC56 →
P79083 0.975 P79083 →
Q9AV81 0.974 Q9AV81 →
A4RDD7 0.974 A4RDD7 →